Home＞Sitemap
Site Top
- News
- Latest News
- Photos
- Categories
- Regulatory
- Business
- Organization
- Academia
- Contents
- Commentary
- Lexicon
- The Column
- Leftover Spinraza in 9-Million-Yen Vial Must Be Discarded, Can’t Be Saved for Next Time: MHLW Official(Aug.23)
- 1st Patient Dosed in PIII for Gilteritinib as Post-HCT AML Maintenance Therapy: Astellas(Aug.23)
- Spinraza’s 9.32 Million Yen Price Tag OK’ed for Listing on Aug. 30(Aug.23)
- Takeda Files Japan NDA for Entyvio(Aug.23)
- External Activities of Takeda Unit Axcelead to Go Full Throttle This Autumn: President(Aug.23)
- The next ebook update will be provided on August 28.
